JP2708749B2 - 修飾型ｔＰＡ含有注射用組成物 - Google Patents

修飾型ｔＰＡ含有注射用組成物

Info

Publication number
JP2708749B2
JP2708749B2 JP62199381A JP19938187A JP2708749B2 JP 2708749 B2 JP2708749 B2 JP 2708749B2 JP 62199381 A JP62199381 A JP 62199381A JP 19938187 A JP19938187 A JP 19938187A JP 2708749 B2 JP2708749 B2 JP 2708749B2
Authority
JP
Japan
Prior art keywords
tpa
amino acid
region
modified
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62199381A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6442442A (en
Inventor
政裕 河原
勇一郎 林
直樹 浅川
純男 渡辺
康夫 三宅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16406817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2708749(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP62199381A priority Critical patent/JP2708749B2/ja
Priority to KR1019880009479A priority patent/KR910009366B1/ko
Priority to NO883520A priority patent/NO178325C/no
Priority to DK443988A priority patent/DK443988A/da
Priority to DE8888113000T priority patent/DE3877277T2/de
Priority to CA000574367A priority patent/CA1338699C/en
Priority to AT88113000T priority patent/ATE84220T1/de
Priority to ES88113000T priority patent/ES2052651T3/es
Priority to EP88113000A priority patent/EP0303251B1/en
Publication of JPS6442442A publication Critical patent/JPS6442442A/ja
Priority to US07/900,796 priority patent/US5425943A/en
Priority to GR920402266T priority patent/GR3006748T3/el
Publication of JP2708749B2 publication Critical patent/JP2708749B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP62199381A 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物 Expired - Lifetime JP2708749B2 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP62199381A JP2708749B2 (ja) 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物
KR1019880009479A KR910009366B1 (ko) 1987-08-10 1988-07-27 수식형 tPA 함유 주사용 조성물
NO883520A NO178325C (no) 1987-08-10 1988-08-08 Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
DK443988A DK443988A (da) 1987-08-10 1988-08-09 Injektionspraeparat indeholdende modificeret tpa
AT88113000T ATE84220T1 (de) 1987-08-10 1988-08-10 Injektionszusammensetzung, die modifiziertes tpa enthaelt.
CA000574367A CA1338699C (en) 1987-08-10 1988-08-10 Modified tpa-containing injection composition
DE8888113000T DE3877277T2 (de) 1987-08-10 1988-08-10 Injektionszusammensetzung, die modifiziertes tpa enthaelt.
ES88113000T ES2052651T3 (es) 1987-08-10 1988-08-10 Compuesto para inyecciones conteniendo tpa modificado.
EP88113000A EP0303251B1 (en) 1987-08-10 1988-08-10 Injection composition containing modified tpa
US07/900,796 US5425943A (en) 1987-08-10 1992-06-22 Modified tPA-containing injection composition having increased solubility
GR920402266T GR3006748T3 (https=) 1987-08-10 1993-01-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62199381A JP2708749B2 (ja) 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物

Publications (2)

Publication Number Publication Date
JPS6442442A JPS6442442A (en) 1989-02-14
JP2708749B2 true JP2708749B2 (ja) 1998-02-04

Family

ID=16406817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62199381A Expired - Lifetime JP2708749B2 (ja) 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物

Country Status (11)

Country Link
US (1) US5425943A (https=)
EP (1) EP0303251B1 (https=)
JP (1) JP2708749B2 (https=)
KR (1) KR910009366B1 (https=)
AT (1) ATE84220T1 (https=)
CA (1) CA1338699C (https=)
DE (1) DE3877277T2 (https=)
DK (1) DK443988A (https=)
ES (1) ES2052651T3 (https=)
GR (1) GR3006748T3 (https=)
NO (1) NO178325C (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
US6372716B1 (en) * 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
TW518219B (en) 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
DE69719265T2 (de) * 1996-09-06 2003-12-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
GB8503358D0 (en) * 1985-02-09 1985-03-13 Beecham Group Plc Compounds
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
DK175380B1 (da) * 1985-04-22 2004-09-20 Genentech Inc Mutant af human vævsplasminogenaktivator, DNA-sekvens som koder herfor, replicerbar udtrykkelsesvektor til at udtrykke denne DNA-sekvens, mikroorganisme transformeret med denne vektor, cellekulturer transformeret med denne....
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
US4960702A (en) * 1985-09-06 1990-10-02 Codon Methods for recovery of tissue plasminogen activator
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
GR3006748T3 (https=) 1993-06-30
JPS6442442A (en) 1989-02-14
NO883520L (no) 1989-02-13
NO883520D0 (no) 1988-08-08
ES2052651T3 (es) 1994-07-16
KR890003404A (ko) 1989-04-14
DK443988A (da) 1989-02-11
DE3877277T2 (de) 1993-06-03
KR910009366B1 (ko) 1991-11-14
NO178325B (no) 1995-11-27
ATE84220T1 (de) 1993-01-15
EP0303251B1 (en) 1993-01-07
US5425943A (en) 1995-06-20
EP0303251A3 (en) 1990-01-31
EP0303251A2 (en) 1989-02-15
DK443988D0 (da) 1988-08-09
NO178325C (no) 1996-03-06
DE3877277D1 (de) 1993-02-18
CA1338699C (en) 1996-11-12

Similar Documents

Publication Publication Date Title
KR100491281B1 (ko) 저당함량을가지는안정한알부민무함유재조합인자Vlll의제제
RU2100032C1 (ru) Фармацевтическая композиция, регулирующая гематопоэз
US5770700A (en) Liquid factor IX formulations
JP4589018B2 (ja) エリスロポエチン溶液製剤
US5871736A (en) Liquid immunoglobulin formulations
KR0127754B1 (ko) 항응고제
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
JPH07173076A (ja) 安定化されたヒト組織プラスミノゲン活性化因子組成物の調製法
JPS6021570B2 (ja) ド−パ類の高濃度製剤の製法
JPH0558000B2 (https=)
EP0455725B1 (en) Pharmaceutical formulations of plasminogen activator proteins
JP2708749B2 (ja) 修飾型ｔＰＡ含有注射用組成物
JPH05331071A (ja) カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
PT746334E (pt) Composicao farmaceutica contendo activadores de plasminogeneo
US5114931A (en) Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts
KR940003056B1 (ko) 우로키나제 전구체를 안정화시키는 방법
JPH0678241B2 (ja) ｔＰＡ医薬組成物
JPS62120321A (ja) ｔＰＡ含有医薬組成物
JP2971680B2 (ja) 組織プラスミノーゲン活性化因子含有組成物
JPH0597703A (ja) 改変型組織プラスミノーゲン活性化因子含有組成物
CA2016165A1 (en) Stabilization of organic compounds
JPS62123130A (ja) 水溶性を増加したｔＰＡ含有医薬組成物
JP4025394B2 (ja) 組織プラスミノーゲン活性化因子医薬組成物
JPH0480010B2 (https=)
JP2001081040A (ja) 組織プラスミノーゲンアクティベーター含有組成物

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term